The P in PICO describes the main characteristics of the participants in a study (sex, age range and condition). When annotating the Population or Participants it is important to consider the question that is the focus of the review. This is the population group that the intervention will directly affect. |
Term | Vocabulary URI | Notes |
---|---|---|
Healthy | Use this term if the authors have stated 'Healthy People' i.e. those who are being assessed for prevention of or at risk of diseases |
If the population or group is not specified this field should be left empty.
Examples:
CD number | Review title | Population as stated in the in the inclusion criteria |
---|---|---|
CD012805 | Aluminium adjuvants used in vaccines versus placebo or no intervention | We will include all trial participants regardless of sex, age, ethnicity, diagnosis, comorbidity, and country of residence. |
CD011047 | We included trials in adults (aged 18 years and over) with any condition or disease. | |
CD008077 | Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity | We included studies in which participants were males and females 18 years of age or older who were admitted to hospitals or clinics and treated with subcutaneous injections of heparin including LMWH and UFH. |
Some reviews look at the prevention of or at risk of a condition. In this case the condition field is left blank will likely be annotated as an outcome.
|
|
|
<script type="text/javascript"> AJS.toInit(function(){ AJS.$('#comments-section').hide(); }); for (var i=0; i<nr_li; i++) { // if the element has the class fom 'clasa' parameter if(tags_li[i].getAttribute('class') == 'innerCell'){ tags_li[i].style.overflow = 'visible'; //tags_li[i].style.overflow-y= 'visible'; } } </script> |